Australian pharma group says high manufacturing costs killing drug exports

A pharma industry group in Australia has warned the government that it needs to do something to relieve the high costs of drug manufacturing in the country or continue to lose exports. Drug exports from Australia have fallen to $2.5 billion from $4 billion in 2012. Industry group Medicines Australia blamed high wages, taxes and a tangle of regulations for discouraging drugmakers from building or expanding there. Report

Suggested Articles

McCallum was hit with a warning letter from the FDA for testing issues with its products and failing to keep appropriate records.

The FDA made public a voluntary recall of sterile injectables made by Coastal Meds of Mississippi, after visible particles were found in some vials.

It’s been a strange road for BMS' Opdivo-Yervoy combo in first-line kidney cancer, but the New Jersey drugmaker finally has a go-ahead.